1300251. Before joining Frazier in 2015, Maroun was senior vice president and general counsel of Aptalis Pharmaceuticals from 2012 to 2014. See reviews, photos, directions, phone numbers and more for Aptalis Pharma locations in Bridgewater, NJ. BRIDGEWATER, N.J. & FORT WORTH, Texas--Aptalis Pharmaceutical Technologies announced today that its divestiture from Actavis plc to TPG, a global private investment firm, has been completed. Aptalis Pharma was a subsidiary of Axcan Holdings, which is controlled by TPG Capital, but it was acquired by Forest Labs in 2014. Available Contacts - Free Plug-in! Aptalis Pharma knows its ABCs when it comes to treating CF and GI ailments. Prescriptions Medications listed here may also be marketed under different names in different countries. It offers pancrelipase capsules, ursodiol tablets, porfimer sodium for injections, shake mixes, calorie boosters, clearance devices and multivitamin supplements. Prior to Aptalis, he held a number of executive positions at Eurand, including CEO, … Industry. Spirit of Agios. Aptalis Pharma US, Inc. filed as a Foreign For-Profit Corporation in the State of Texas on Tuesday, March 17, 1992 and is approximately twenty-nine years old, according to public records filed with Texas Secretary of State.A corporate filing is called a foreign filing when an existing corporate entity files in a state other than the state they originally filed in. April 29, 2021. Aptalis Pharma is located at 22 Inverness Center Pkwy, Birmingham, AL.. Posted on March 16, 2015. Adare Pharma Appoints Joseph Del Buono As Vice President, Finance And Chief Financial Officer. Apellis is a global biopharmaceutical company that develops life-changing therapies. The combined company was renamed Aptalis. Get reviews, hours, directions, coupons and more for Aptalis Pharma Us at 845 Center Dr, Vandalia, OH 45377. Over the 12+ years Agios has been in existence, we have remained committed to patients first and to following the science. Before joining Frazier, Rick was Senior Vice President and General Counsel of Aptalis Pharmaceuticals. Aptalis Pharma US, Inc. was formerly known as Axcan Scandipharm, Inc. and changed its name to Axcan Pharma US, Inc. in December 1999. David Lopez’s practice focuses on representation of corporate clients in a wide range of corporate governance, public reporting, capital markets, finance, and liability management matters. Formerly known as Axcan, the company has built itself a strong position in the North American and European gastroenterology and cystic fibrosis markets. Prior to this, he held senior positions in global business development both at Alcon, where he was Region President of Europe, Middle East and Africa, and Novartis Pharmaceuticals, where he served as President of Novartis Pharmaceuticals, Canada. Both Axcan and Eurand produced and marketed versions of the drug pancrelipase, which is used in the treatment of symptoms related to cystic fibrosis. Read about our comprehensive health insurance programs, our financial planning and protection package, including a 401k plan, stock-purchase option, and life insurance and disability coverage. The global market for cystic fibrosis therapeutics expected to reach $14.2 billion by 2027, growing at CAGR 8.2% over the forecast period, driven by rising prevalence of cystic fibrosis, recent approvals of CFTR modulators and R&D initiatives taken by … He is … Since the market is the benchmark, the market's beta is always 1. Salaries posted anonymously by Aptalis Pharma employees. BRIDGEWATER, New Jersey and FORT WORTH, Texas – Aptalis Pharmaceutical Technologies recently announced that its divestiture from Actavis plc to TPG, a global private investment firm, has been completed. Free and open company data on Canada company Aptalis Pharma Canada Inc. (company number 4466179), 597 SIR-WILFRID-LAURIER BLVD., MONT-SAINT-HILAIRE, QC, J3H 6C4 Aptalis, Forest, Merck, and Watson Patient Assistance Programs. Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. with “APTALIS 5” (3) Capsules: 10,000 USP units of lipase; 32,000 USP units of protease; 42,000 USP units of amylase. TPG to support Adare Pharmaceuticals’ growth as a platform for partnerships, acquisitions and new product development BRIDGEWATER, New Jersey and FORT WORTH, Texas, April 2, 2015 – Aptalis Pharmaceutical Technologies announced today that its divestiture from Actavis plc to TPG, a global private investment firm, has been completed. - Support and manage all administrative business for President, US Specialty Pharma & Vice President, Global Total Rewards & HR Operations - Maintain intricate calendars and schedule all internal and external executive meetings - Schedule all domestic and international travel arrangements and itineraries Non-US country and region specific information is not available on this page. *Aptalis Pharmatech, Inc. (previously known as Eurand, Inc.), Cephalon, Inc. a wholly-owned subsidiary of Teva Pharmaceuticals Industries Ltd., and Anesta AG Our company endeavors to obtain Orange Book listed formulation patents for our U.S. NDA products Brought to you by merchantcircle. She has previously served on multiple boards including Albireo (NASDAQ:ALBO), Aptalis Pharma (acquired by Forest Labs in 2014), and Elevation Pharmaceuticals (acquired by Sunovion in 2012). He has played leadership roles on TPG’s investments in Adare Pharmaceuticals, Aptalis, BVI, EnvisionRx, Immucor, and Par Pharmaceutical. This is the Aptalis Pharma company profile. Aptalis Pharmaceutical Technologies endeavors to offer partners the most effective patent protection possible from the company’s broad and diversified portfolio. He has played leadership roles on TPG’s investments in Adare Pharmaceuticals, Aptalis, BVI, EnvisionRx, Immucor, and Par Pharmaceutical. APTALIS PHARMA CANADA INC. - MONT-SAINT-HILAIRE QC CANADA. Allergan plc manufactures, markets and/or distributes more than 110 drugs in the United States. Aptalis Pharma knows its ABCs when it comes to treating CF and GI ailments. Aptalis Pharma was a subsidiary of Axcan Holdings, which is controlled by TPG Capital, but it was acquired by Forest Labs in 2014. Its specialized capabilities include taste-masking and customized drug release, … Aptalis Pharmaceutical Technologies (now Adare Pharmaceuticals) Pharmaceuticals Lawrenceville, New Jersey 6,531 followers Dr. Thieroff-Ekerdt has previously served as Chief Medical Officer at Kaleido Biosceinces, Strongbridge Biopharma Plc, Aptalis Pharmaceuticals, and Eurand Pharmaceuticals and as Vice President Clinical and Medical Affairs at Bayer Consumer Care. Previously, he was President of Aptalis Pharmaceutical Technologies. In addition, he has served in numerous senior executive roles for APP Pharmaceuticals, including as Executive Vice President, Chief Administrative Officer, General Counsel, and Business Development Officer. Key Principal. Dr. Sherif joined Oculis from Novartis where he served as Entrepreneur in Residence at Novartis Venture Fund during 2017. Negative Outlook. Get reviews, hours, directions, coupons and more for Aptalis Pharma Us at 845 Center Dr, Vandalia, OH 45377. Our legacy is rooted in a powerful set of strengths, values and competencies. Aptalis Pharma US, Inc. markets pharmaceutical products and services for the treatment of gastrointestinal diseases and disorders. Pros. 38 39 CN r c iv d r s rch gr nts from F rring O ym us nd A Vi nd s k r’s f s from 40 Pfizer, Abbvie, Takeda, Janssen, Ferring, Menarini and Tillotts Phramaceuticals. PCT/CA2018/051098. Actavis, Inc. was a global pharmaceutical company that was involved in the development, manufacture, and distribution of its own brand named pharmaceuticals as well as the manufacture and distribution of generic pharmaceutical products, particularly a number of generic products from a company it had acquired, Watson Pharmaceuticals. TPG, one of the most active private equity investors in healthcare, bought the drugmaker, formerly known as Axcan Pharma, for $1.3 billion in 2008 and merged it with Eurand Pharmaceuticals … 4/2/2015. Empowered to make things happen. Aptalis Pharma Us, Inc. 100 Somerset Corporate Boulevard Bridgewater, NJ 08807 Other Information Entity Status: Active Type of Entity: Foreign Profit Corporation Entity Creation Date: Oct 27, 1995 Days in Business: 8568 days Company Description. Eurand Pharmaceuticals was a producer and contract manufacturer of sustained release dosage forms or taste-masked pharmaceutical dosage forms. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Axcan, with the recent acquisition of Eurand Pharmaceuticals Inc., is a privately held, leading global specialty pharmaceutical company with clinical, manufacturing and … Saptalis is an R&D driven pharmaceutical company with a focus on development, manufacturing and successful commercialization of multiple complex niche products such as topical creams, gels and ointments; oral suspensions and sterile suspensions and nanoemulsions. Aerie Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update. We have built on our core differentiators to make a positive difference for patients through truly differentiated therapies. We are a specialty pharmaceutical company with emphasis on developing complex generics, difficult to formulate dosage forms and novel drug delivery systems. Aptalis Pharma knows its ABCs when it comes to treating CF and GI ailments. The company develops and sells drugs mainly to treat cystic fibrosis (CF) and gastrointestinal (GI) conditions. Its Urso line treats liver disease; Carafate and Sulcrate treat ulcers; and Canasa and Salofalk offer relief for inflammatory bowel diseases. Search for other Pharmaceutical Products-Wholesale & … Prior to joining TPG in 2011, Dr. Schilling managed sales and marketing for the U.S. pharmaceutical business at Abbott and was a Partner at McKinsey & Company. Aerie Pharmaceuticals Completes Enrollment of its Phase 2b Clinical Trial of AR-15512 (TRPM8 Agonist) Ophthalmic Solution for the Treatment of Patients with Dry Eye Disease. Next Project Fabri-Form. Aptalis Pharma Canada Inc. is governed under the Canada Business Corporations Act - 2013-11-08. Mr. Bought by Forest Labs and eviscerated by their culture of … By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology. A free inside look at Aptalis Pharma salary trends based on 7 salaries wages for 7 jobs at Aptalis Pharma. 7 Sept. 2018. John Fraher is the former CEO of Adare Pharma Solutions. The company develops and sells drugs mainly to treat cystic fibrosis (CF) and gastrointestinal (GI) conditions. April 28, 2021. The company also announced that its new name is Adare Pharmaceuticals and John Fraher, who was president of Aptalis Pharmaceutical Technologies, has been named the CEO. Aptalis Pharma is a privately held, leading specialty pharmaceutical company providing innovative, effective therapies for unmet medical needs including cystic … Please contact the business for updated hours/services due to the COVID-19 advisory. Ranbaxy Labs. All content is posted anonymously by employees working at Aptalis Pharma. Aixvy Thompson | Vandalia, Ohio, United States | Stability Program Lead at Adare Pharma Solutions (Formerly Aptalis Pharmatech) | 280 connections | View Aixvy's homepage, profile, activity, articles The company also announced that its new name is Adare Pharmaceuticals and John Fraher, who was president of Aptalis Pharmaceutical Technologies, has been named the CEO. Aptalis Pharma (known as Axcan Pharma until May 2011) is a privately-held, leading specialty pharmaceutical company that develops and markets a wide range of products to treat gastrointestinal diseases and disorders, such as inflammatory bowel disease, cholestatic liver diseases, irritable bowel syndrome, and complications related to pancreatic Aptalis Holdings Inc. – AGREEMENT AND PLAN OF MERGER BY AND AMONG AXCAN HOLDINGS INC., AXCAN LONE STAR INC., MPEX PHARMACEUTICALS, INC. AND THE SECURITYHOLDERS’ REPRESENTATIVE COMMITTEE April 11, 2011. He has also held numerous senior executive roles for APP Pharmaceuticals, Abraxis BioScience and American BioScience Inc. Aptalis Pharmaceutical Technologies announced today that its divestiture from Actavis plc to TPG, a global private investment firm, has been completed Pharmaceutical Manufacturing Manufacturing Sector Pharmaceutical preparations. The company also announced that its new name is Adare Pharmaceuticals and John Fraher, who was president of Aptalis Pharmaceutical Technologies, has been named the CEO. Adare Pharma Solutions is a global technology-driven CDMO providing turnkey product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health, and OTC markets. Prior to Aptalis, he held a number of executive positions at Eurand, including CEO, President, and Chief Commercial Officer. FLUTTER® Mucus Clearance Device Instructions for Use PRODUCT DESCRIPTION The FLUTTER® mucus clearance device is shaped like a pipe with a hardened plastic mouthpiece at one end, a plastic protective, perforated cover at the other end, and a high-density stainless Company Profile: Eurand Pharmaceuticals (now Aptalis) is a privately held, leading specialty pharmaceutical company providing innovative, effective therapies for unmet medical needs, with focused expertise in the fields of cystic fibrosis and gastroin. Aptalis Pharma has, up to this point, been a great place to work allowing the freedom to work hard, play hard and have time to spend with your family. Glassdoor gives you an inside look at what it's like to work at Aptalis Pharma, including salaries, reviews, office photos, and more. Previous Project Midwest Express Group. The company offers therapies for cystic fibrosis and gastrointestinal disorders. Sponsored Links. Search for other Pharmaceutical Products-Wholesale … Aptalis Pharma, Inc., a global specialty pharmaceutical company focused on gastrointestinal diseases and cystic fibrosis , announced the results of two global Phase 3 studies of Aeroquin™ . Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. He has more than 30 years of experience in the pharmaceutical and life science industries. John Fraher See more contacts. Aptalis Pharmaceutical Technologies Release: Allegra Dry Syrup 5% Launches In Japan. Bridgewater, NJ … Bolivia Drugs & Pharmaceutical Industry Pharmaceutical and Medicine Manufacturing in Bolivia Pharmaceutical Companies in Bolivia Suppliers Manufacturers Exporters & Importers pharmaceutical manufacturers in Bolivia Manufacturer Pharmaceuticals Suppliers in Americas pharmaceutical technology Americas Manufacturing Industry in Bolivia Pharmaceuticals … Buyout firm TPG bought the drugmaker, formerly known as Axcan Pharma, for $1.3 billion in 2008 and merged it with Eurand Pharmaceuticals in 2011. Please see the accompanying list of the products available through this Program. I worked at Aptalis Pharma full-time for more than a year. The company was founded in 1991 and is based in Birmingham, Alabama. 8/27/2015. Diffucaps Customized Release Technology from Adare Pharmaceuticals. Cons. Formerly traded publicly on NASDAQ, Axcan was acquired by TPG Capital in 2008. Aptalis Pharma US, Inc. Overview. Find 37 listings related to Aptalis Pharma in Bridgewater on YP.com. A free inside look at Aptalis Pharma salary trends based on 7 salaries wages for 7 jobs at Aptalis Pharma. Manufacturer of pharmaceutical products for the treatment of gastrointestinal diseases. Allergan plc manufactures, markets and/or distributes more than 110 drugs in the United States. Aptalis Pharma General Information Description. (908) 927-9600. He has played leadership roles on TPG’s investments in Adare Pharmaceuticals, Aptalis, BVI, EnvisionRx, Immucor, and Par Pharmaceutical. Levered/Unlevered Beta of Aptalis Pharma Canada Inc ( AXP.XX1 | CAN) Beta is a statistical measure that compares the volatility of a stock against the volatility of the broader market, which is typically measured by a reference market index. Collegial atmosphere, supportive management and hard working team. Aptalis Pharma is a pharmaceuticals company based out of 100 SOMERSET CORPORATE, BRIDGEWATER, New Jersey, United States. As a wholly owned subsidiary of Forest Laboratories and Actavis, Aptalis operates as a specialty pharmaceutical company focusing on cystic fibrosis and gastrointestinal disorders. Ltd. v. Vertex Pharmaceuticals, Inc. Previously, he was President of Aptalis Pharmaceutical Technologies. The company has corporate status: Inactive - Discontinuedon 2014-05-30. In one of the first inter partes review (“IPR”) petitions to challenge the validity of a patent protecting a branded pharmaceutical, Knobbe Martens achieved a positive settlement for Ranbaxy. Who is Actavis Inc in the United States? We would like to show you a description here but the site won’t allow us. Aptalis Pharmaceutical Technologies has been divested from Actavis to TPG, a global private investment firm. Aptalis Pharma Inc. Website. This portfolio comprises patents with claims directed to the company’s formulation technologies and related materials, processes, equipment, and methods of manufacture.
Jiangsu Cuisine Characteristics, South Hills Country Club Pittsburgh Membership Cost, What Does It Take To Be Innovative, Morse High School Tennis, Lab Gruppen 4 Channel Amplifier, Woodlice Choice Chamber Experiment Method, Medieval Mounted Soldier Crossword Clue 7 Letters, Vampires Vs Zombies Comic,